The authors analyzed a preliminary report of patient-reported outcomes ( PROs ) among men who received high-dose radiation therapy ( RT ) on Radiation Therapy Oncology Group study 0126 ( a phase 3 dose-escalation trial ) with either 3-dimensional conformal RT ( 3D-CRT ) or intensity-modulated RT ( IMRT ) .